作者：
Ewart,L. [1]
;
Milne,A. [2]
;
Adkins,D. [3]
;
Benjamin,A. [4]
;
Bialecki,R. [5]
;
Chen,Y. ;
Ericsson,A.-C. ;
Gardner,S. ;
Grant,C. ;
Lengel,D. ;
Lindgren,S. ;
Lowing,S. ;
Marks,L. ;
Moors,J. ;
Oldman,K. ;
Pietras,M. ;
Prior,H. ;
Punton,J. ;
Redfern,W.S. ;
Salmond,R. ;
Skinner,M. ;
Some,M. ;
Stanton,A. ;
Swedberg,M. ;
Finch,J. ;
Valentin,J.-P.
作者单位：
Charles River Laboratories, Tranent, Edinburgh, Scotland, United Kingdom
[1]
Global Safety Pharmacology, Global Safety Assessment, AstraZeneca, S?dert?lje, Sweden
[2]
Statistics, Discovery Sciences, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United
[3]
Global Safety Assessment, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United
[4]
Global Safety Pharmacology Global Safety Assessment, AstraZeneca, Waltham, MA, United States
[5]
发布时间
2013-11-20
换一批
